ACUTAAS

Acutaas Chemicals Financial Results

₹3,159.40+0.09%
Market cap
₹25,866 crore
P/E
67.0
P/B
15.64
ROE
24.1%
Dividend yield
0.08%

For the year ended Mar 2022, Acutaas Chemicals reported revenue of ₹520 crore and net profit of ₹72 crore, against ₹613 crore and ₹83 crore a year earlier.

Acutaas Chemicals annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Acutaas Chemicals annual profit and loss (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue5206137131,0001,3291,451
Expenses415490585768848908
Operating profit105123128232481543
Operating margin %20%20%18%23%36%37%
Other income34-25164126
Interest626633
Depreciation101216273638
Profit before tax9111282216483529
Tax %21%26%41%26%26%27%
Net profit728349160356387
EPS (₹)9.8711.435.8019.3943.5147.17
Dividend payout %——————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Acutaas Chemicals financial results — frequently asked questions

What is Acutaas Chemicals' annual revenue and net profit?

For the financial year ended Mar 2022, Acutaas Chemicals' revenue was ₹520 crore and net profit ₹72 crore; net profit fell 13.25% from ₹83 crore in Mar 2023.

How fast has Acutaas Chemicals grown over three years?

From Mar 2025 to Mar 2022, Acutaas Chemicals' revenue grew at a compound annual rate of -19.6% and net profit at -23.4%. Past growth does not indicate future results.

What is the EPS of Acutaas Chemicals?

Annual EPS for Mar 2022 was ₹9.87.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Acutaas Chemicals With ATS

Track ACUTAAS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.